A detailed history of Pacer Advisors, Inc. transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 424 shares of MORF stock, worth $24,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
424
Previous 1,030 58.83%
Holding current value
$24,163
Previous $36,000 61.11%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$26.12 - $34.07 $15,828 - $20,646
-606 Reduced 58.83%
424 $14,000
Q1 2024

May 10, 2024

BUY
$26.64 - $40.31 $27,439 - $41,519
1,030 New
1,030 $36,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.